Scientific discoveries won’t change the world if no one knows about them, and innovative treatments are worthless if patients can’t access them.
To that end, marketing and commercialization experts across the life sciences work day-in and day-out to get the message out — whether by conveying the patient’s need for a new drug to payers and physicians, or by developing direct-to-consumer advertising materials that meet patients where they are in their care journey.
These leaders translate the hard-fought science into comprehensible products that regulators and physicians alike can see the value in. They push the envelope of what it means to be patient-focused, forging partnerships with industry and nonprofit stakeholders to expand access to life saving medications.
At their core, these are the storytellers framing the narrative of the life sciences industry for patients around the world.
These are the 2023 PharmaVoice 100 brand and commercialization pros.
Violet Aldaia
President, H4B Chelsea
Permission granted by Violet Aldaia
“I keep my teams inspired and motivated by putting patients at the center of everything we do.”
Nicole Benedetto
Director, customer experience and commercial acceleration, Organon
Permission granted by Nicole Benedetto
“I love imagining what could be and creating a roadmap to turn it into reality — and doing that with incredibly talented colleagues is the best part of my job.”
LeAnna Carey
Founder, Women Who Innovate
Permission granted by LeAnna Carey
“Sisyphus had it all wrong and Da Vinci had it all right — unrelenting curiosity wins every time.”
Lauren D’Angelo
Chief commercial officer, Alpha Cognition
Permission granted by Lauren D’Angelo
“The ability to motivate and inspire others has always been an intuitive skill and not something that I can learn or practice.”
Cynthia Meehan
Former executive vice president, client team lead, Ogilvy Health
Permission granted by Cynthia Meehan
“Let’s laugh and have some fun together while working toward a bigger vision.”
Joanne Monahan
Senior vice president, U.S. oncology, Merck & Co.
Permission granted by Joanne Monahan
“Our focus on precision medicine will significantly heighten, expanding and improving outcomes for people with cancer.”
Susanne Munksted
Chief precision medicine officer, Diaceutics
Permission granted by Susanne Munksted
“Our vision [is] that every patient deserves to be equally, timely and accurately diagnosed to receive the right therapy to extend their lives.”
Sy Pretorius
Chief operating officer, president, outsourced solutions, Eversana
Permission granted by Sy Pretorius
“We are finally becoming patient-centric. I’m not sure why it took us so long, but I’m excited that [it’s] happening across our industry.”
Source link
#PharmaVoice #Brand #commercialization #pros
